1.59 0.02 (1.27%)

70.00% Fall from 52W High

13,650 XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for MetaVia Inc. is on 28 Mar 2025 for the purpose of NeuroBo Pharmaceuticals Inc Annual Report for 2024 See details


Insider Trading disclosures for MetaVia Inc.

The latest disclosure was made by Marshall Woodworth in MetaVia Inc. where a trade of 3,417 Common Stock done at an average price of $1.5 was reported to US exchanges on March 1, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Marshall Woodworth Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. 01 Mar 2025 3,417 30,079 (0%) 0% 1.5 4,989 Common Stock
Hyung Heon Kim Director, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. 01 Mar 2025 2,795 61,004 (0%) 0% 1.5 4,081 Common Stock
Hyung Heon Kim Director, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.55 per share. 30 Nov 2024 2,867 63,799 (0%) 0% 2.6 7,311 Common Stock
Hyung Heon Kim Director, CEO & President Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.60 per share. 11 Aug 2024 11,467 66,666 (0%) 0% 3.6 41,281 Common Stock
Andrew I. Koven Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2024 5,051 17,552 (0%) 0% 0 Common Stock
D. Gordon Strickland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2024 5,051 17,552 (0%) 0% 0 Common Stock
Mark A. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2024 5,051 9,740 (0%) 0% 0 Common Stock
Jason L. Groves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2024 5,051 17,552 (0%) 0% 0 Common Stock
James Patrick Tursi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2024 5,051 9,072 (0%) 0% 0 Common Stock
Michael Salsbury Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2024 5,051 17,552 (0%) 0% 0 Common Stock
Marshall Woodworth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 33,496 33,496 (0%) 0% 0 Common Stock
Tursi Patrick James Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 25,000 25,000 (0%) 0% 0 Common Stock
James Patrick Tursi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 7,157 32,157 (0%) 0% 0 Common Stock
Hyung Heon Kim Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2023 625,064 625,064 (4%) 4% 0 Common Stock
Andrew I. Koven Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2023 12,500 100,000 (0%) 0% 0 Common Stock
Andrew I. Koven Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2023 87,500 87,500 (0%) 0% 0 Common Stock
D. Gordon Strickland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2023 87,500 87,500 (0%) 0% 0 Common Stock
D. Gordon Strickland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2023 12,500 100,000 (0%) 0% 0 Common Stock
Mark A. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2023 25,000 25,000 (0%) 0% 0 Common Stock
Mark A. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2023 12,500 37,500 (0%) 0% 0 Common Stock
Jason L. Groves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2023 12,500 100,000 (0%) 0% 0 Common Stock
Jason L. Groves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2023 87,500 87,500 (0%) 0% 0 Common Stock
Michael Salsbury Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2023 12,500 100,000 (0%) 0% 0 Common Stock
Michael Salsbury Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2023 87,500 87,500 (0%) 0% 0 Common Stock
Na Yeon Kim Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2023 12,500 101,459 (0%) 0% 0 Common Stock
Na Yeon Kim Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2023 87,500 88,959 (0%) 0% 0 Common Stock
Na Yeon Kim Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 26 Jul 2022 4,671 4,671 (0%) 0% 0 Common Stock
Andrew I. Koven Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 20,000 20,000 - - Nonstatutory Stock Option (right to buy)
D. Gordon Strickland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 20,000 20,000 - - Nonstatutory Stock Option (right to buy)
Jason L. Groves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 20,000 20,000 - - Nonstatutory Stock Option (right to buy)
Michael Salsbury Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 20,000 20,000 - - Nonstatutory Stock Option (right to buy)
Na Yeon Kim Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 20,000 20,000 - - Nonstatutory Stock Option (right to buy)
Jeong Gu Kang Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 20,000 20,000 - - Nonstatutory Stock Option (right to buy)
Hyung Heon Kim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 20,000 20,000 - - Nonstatutory Stock Option (right to buy)
D. Gordon Strickland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2022 40,000 40,000 - - Non-qualified Stock Option (right to buy)
Andrew I. Koven Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Sep 2021 60,000 60,000 - - Nonstatutory Stock Option (right to buy)
Douglas J. Swirsky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2020 60,000 60,000 - - Non-qualified stock option (right to buy)
Jason L. Groves Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2020 60,000 60,000 - - Non-qualified stock option (right to buy)
Steven R. Gullans Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2020 60,000 60,000 - - Non-qualified stock option (right to buy)
Michael Salsbury Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2020 60,000 60,000 - - Non-qualified stock option (right to buy)
Na Yeon Kim Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2020 60,000 60,000 - - Non-qualified stock option (right to buy)
Jeong Gyun Oh Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2020 60,000 60,000 - - Non-qualified stock option (right to buy)
Mark Versavel Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2019 45,724 45,724 - - Stock Option (right to buy)
Mark Versavel Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2019 297,206 297,206 - - Stock Option (right to buy)
Na Yeon Kim Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2019 4,335,800 4,335,800 (27%) 27% - Common Stock
Na Yeon Kim Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2019 1,864,799 1,864,799 (11%) 11% - Common Stock
Na Yeon Kim Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2019 1,121,190 1,121,190 (7%) 7% - Common Stock
Jeong Gyun Oh Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2019 1,817,842 1,817,842 (11%) 11% - Common Stock
Jeong Gyun Oh Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2019 240,051 240,051 (1%) 1% - Common Stock
Charles L. Bisgaier Director, Chief Scientific Off. & Chair, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 100,000 1,348,914 (8%) 0% 0 Common Stock
Pedro Lichtinger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 15,000 74,833 (0%) 0% 0 Common Stock
Steven R. Gullans Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 300,000 300,000 (1%) 2% 0 Common Stock
Andrew H. Sassine Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 15,000 151,264 (0%) 0% 0 Common Stock
Seth Reno Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 100,000 118,286 (0%) 0% 0 Common Stock
Kenneth Kousky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 15,000 26,935 (0%) 0% 0 Common Stock
Steven R. Gullans Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2018 50,000 50,000 - - Employee Stock Option (right to buy)
Steven R. Gullans Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2018 50,000 50,000 - - Employee Stock Option (right to buy)
Steven R. Gullans Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2018 150,000 150,000 - - Employee Stock Option (right to buy)
Steven R. Gullans Director, Interim President & CEO Purchase of securities on an exchange or from another person at price $ 7.00 per share. 08 Feb 2018 71,429 930,252 (8%) 0% 7 500,003 Common Stock
Seth Reno Chief Commercial Officer Purchase of securities on an exchange or from another person at price $ 7.00 per share. 08 Feb 2018 14,286 18,286 (0%) 0% 7 100,002 Common Stock
Pedro Lichtinger None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2018 10,800 10,800 - - Stock Option(right to buy)
Steven R. Gullans Director, Interim President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2018 60,000 60,000 - - Employee Stock Option (right to buy)
Andrew H. Sassine None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2018 10,800 10,800 - - Stock Option (right to buy)
P. Kent Hawryluk None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2018 10,800 10,800 - - Stock Option (right to buy)
Kenneth Kousky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2018 10,800 10,800 - - Stock Option (right to buy)
Charles L. Bisgaier Director, Chief Scien Officer & Chair, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2018 48,000 48,000 - - Stock Option (right to buy)
Jeffrey S. Mathiesen Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2018 48,000 48,000 - - Employee Stock Option (right to buy)
Seth Reno Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2018 48,000 48,000 - - Employee Stock Option (right to buy)
Lee Scott Golden Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2018 148,000 148,000 - - Employee Stock Option (right to buy)
Jeffrey S. Mathiesen Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Aug 2017 3,207 0 - - Employee Stock Option (right to buy)
Jeffrey S. Mathiesen Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. 14 Aug 2017 3,207 14,134 (0%) 0% 3.6 11,513 Common Stock
Jeffrey S. Mathiesen Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Aug 2017 3,000 45,093 - - Employee Stock Option (right to buy)
Jeffrey S. Mathiesen Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.59 per share. 10 Aug 2017 3,000 10,927 (0%) 0% 3.6 10,770 Common Stock
Charles L. Bisgaier Director, Chief Scientific Off. & Chair, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.34 per share. 31 Jul 2017 4,474 1,248,914 (11%) 0% 1.3 6,013 Common Stock
Charles L. Bisgaier Director, Chief Scientific Off. & Chair, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2017 4,474 0 - - Employee Stock Option (right to buy)
Steven R. Gullans Director, Interim President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2017 60,000 60,000 - - Employee Stock Option (right to buy)
Lee Scott Golden Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2017 20,000 20,000 - - Employee Stock Option (right to buy)
Pedro Lichtinger None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Mar 2017 7,920 7,920 - - Warrant to Purchase Common Stock
Pedro Lichtinger None Purchase of securities on an exchange or from another person at price $ 9.47 per share. 10 Mar 2017 10,559 59,833 (0%) 0% 9.5 99,994 Common Stock
Steven R. Gullans None Purchase of securities on an exchange or from another person at price $ 9.47 per share. 10 Mar 2017 52,798 858,823 (9%) 0% 9.5 499,997 Common Stock
Steven R. Gullans None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Mar 2017 39,599 39,599 - - Warrant to Purchase Common Stock
Andrew H. Sassine None Purchase of securities on an exchange or from another person at price $ 9.47 per share. 10 Mar 2017 21,119 136,264 (1%) 0% 9.5 199,997 Common Stock
Andrew H. Sassine None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Mar 2017 15,840 15,840 - - Warrant to Purchase Common Stock
P. Kent Hawryluk None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Mar 2017 18,750 18,750 - - Warrant to Purchase Common Stock
P. Kent Hawryluk None Purchase of securities on an exchange or from another person at price $ 9.47 per share. 10 Mar 2017 25,000 81,889 (0%) 0% 9.5 236,750 Common Stock
Kenneth Kousky None Other type of transaction at price $ 0.00 per share. 01 Feb 2017 110,428 6,463 (0%) 1% 0 Common Stock
Kenneth Kousky None Other type of transaction at price $ 0.00 per share. 01 Feb 2017 101,406 4,472 (0%) 1% 0 Common Stock
Mina Sooch Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Nov 2016 120,000 600,000 - - Employee Stock Option (right to buy)
Lee Scott Golden Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Oct 2016 126,000 126,000 - - Employee Stock Option (right to buy)
Mina Sooch Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2016 120,000 480,000 - - Employee Stock Option (right to buy)
Jeffrey S. Mathiesen Chief Financial Officer 10 Aug 2016 3,927 3,927 - - Common Stock
Jeffrey S. Mathiesen Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Aug 2016 4,000 7,927 - - Common Stock
Charles L. Bisgaier Director, Chair & Chief Scientific Off., Ten Percent Owner 10 Aug 2016 59,561 0 - - Series A Convertible Preferred Stock
Charles L. Bisgaier Director, Chair & Chief Scientific Off., Ten Percent Owner 10 Aug 2016 59,561 59,561 - - Common Stock
Charles L. Bisgaier Director, Chair & Chief Scientific Off., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 10 Aug 2016 6,515 66,076 - - Common Stock
Charles L. Bisgaier Director, Chair & Chief Scientific Off., Ten Percent Owner 10 Aug 2016 16,144 82,220 - - Common Stock
Charles L. Bisgaier Director, Chair & Chief Scientific Off., Ten Percent Owner 10 Aug 2016 19,228 19,228 - - Common Stock
Charles L. Bisgaier Director, Chair & Chief Scientific Off., Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Aug 2016 51,750 1,244,440 - - Common Stock
Pedro Lichtinger None 10 Aug 2016 39,274 39,274 - - Common Stock
Pedro Lichtinger None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Aug 2016 10,000 49,274 - - Common Stock
Mina Sooch Director, President & CEO 10 Aug 2016 11,078 0 - - Series A Convertible Preferred Stock
Mina Sooch Director, President & CEO 10 Aug 2016 11,078 11,078 - - Common Stock
Mina Sooch Director, President & CEO Other type of transaction at price $ 0.00 per share. 10 Aug 2016 1,212 12,290 - - Common Stock
Mina Sooch Director, President & CEO 10 Aug 2016 27,141 39,431 - - Common Stock
Mina Sooch Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Aug 2016 52,500 693,732 - - Common Stock
Steven R. Gullans None 10 Aug 2016 306,025 306,025 - - Common Stock
Steven R. Gullans None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Aug 2016 500,000 806,025 - - Common Stock
Andrew H. Sassine None 10 Aug 2016 75,080 0 - - Series A Convertible Preferred Stock
Andrew H. Sassine None 10 Aug 2016 75,080 75,080 - - Common Stock
Andrew H. Sassine None Other type of transaction at price $ 0.00 per share. 10 Aug 2016 8,212 83,292 - - Common Stock
Andrew H. Sassine None 10 Aug 2016 31,853 115,145 - - Common Stock
Seth Reno Chief Commercial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Aug 2016 4,000 4,000 - - Common Stock
David Lowenschuss Chief Legal Off. & Secretary Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Aug 2016 11,120 806,247 - - Common Stock
Carmen Daniela Oniciu Vice President 10 Aug 2016 2,237 0 - - Series A Convertible Preferred Stock
Carmen Daniela Oniciu Vice President 10 Aug 2016 2,237 152,156 - - Common Stock
Carmen Daniela Oniciu Vice President Other type of transaction at price $ 0.00 per share. 10 Aug 2016 245 152,401 - - Common Stock
P. Kent Hawryluk None 10 Aug 2016 7,457 0 - - Series A Convertible Preferred Stock
P. Kent Hawryluk None 10 Aug 2016 7,457 7,457 - - Common Stock
P. Kent Hawryluk None Other type of transaction at price $ 0.00 per share. 10 Aug 2016 816 8,273 - - Common Stock
P. Kent Hawryluk None 10 Aug 2016 23,616 31,889 - - Common Stock
P. Kent Hawryluk None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Aug 2016 25,000 56,889 - - Common Stock
Kenneth Kousky None 10 Aug 2016 95,439 0 - - Series A Convertible Preferred Stock
Kenneth Kousky None 10 Aug 2016 95,439 95,439 - - Common Stock
Kenneth Kousky None Other type of transaction at price $ 0.00 per share. 10 Aug 2016 10,439 105,878 - - Common Stock
Kenneth Kousky None 10 Aug 2016 116,891 116,891 - - Common Stock
Kenneth Kousky None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Aug 2016 1,000 1,000 - - Common Stock
Jeffrey S. Mathiesen Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2016 210,000 210,000 - - Employee Stock Option (right to buy)
Charles L. Bisgaier Director, Chief Scien. Officer & Chair, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2016 150,000 150,000 - - Employee Stock Option (right to buy)
Pedro Lichtinger None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2016 60,000 60,000 - - Stock Option (right to buy)
Mina Sooch Director, President & CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2016 360,000 360,000 - - Employee Stock Option (right to buy)
Steven R. Gullans None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2016 60,000 60,000 - - Stock Option (right to buy)
Andrew H. Sassine None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2016 60,000 60,000 - - Stock Option (right to buy)
Seth Reno Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2016 150,000 150,000 - - Employee Stock Option (right to buy)
David Lowenschuss CLO & Secretary, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2016 78,000 78,000 - - Employee Stock Option (right to buy)
Carmen Daniela Oniciu Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2016 102,000 102,000 - - Employee Stock Option (right to buy)
P. Kent Hawryluk None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2016 60,000 60,000 - - Stock Option (right to buy)
Kenneth Kousky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2016 60,000 60,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures